Please check your internet connection and try again.
## Potassium Chloride
### Overview
Potassium chloride (KCL) is an essential electrolyte used to treat or prevent hypokalemia. It is available in oral and intravenous formulations.
### Primary Indications
* Treatment of hypokalemia.
* Prevention of hypokalemia in patients at risk.
### Adult Dosing
* **Oral:**
* **Treatment of hypokalemia:** Typically 20-60 mEq per day in divided doses. Higher doses may be necessary under close medical supervision.
* **Prevention of hypokalemia:** Typically 10-40 mEq per day.
* **Intravenous (IV):** Dosing is highly individualized based on serum potassium levels, severity of deficit, and patient condition.
* **Mild hypokalemia (serum K+ 3.0-3.5 mEq/L):** 10-20 mEq infused over several hours.
* **Moderate hypokalemia (serum K+ 2.5-2.9 mEq/L):** 20-40 mEq infused over several hours.
* **Severe hypokalemia (serum K+ <2.5 mEq/L):** May require more aggressive IV replacement, often with central venous access, at rates up to 40 mEq/hour, but **must not exceed 10 mEq/hour via peripheral IV** to minimize phlebitis and pain. **Maximum dose is generally 200 mEq in 24 hours**, but this can be exceeded in life-threatening situations under expert management.
### Pediatric Dosing
* **Oral:**
* **Treatment of hypokalemia:** 1-2 mEq/kg/day divided into 1-4 doses.
* **Prevention of hypokalemia:** 0.5-1 mEq/kg/day divided into 1-4 doses.
* Maximum daily dose: Generally 20 mEq/day for infants and up to 40 mEq/day for older children, but individualization is key.
* **Intravenous (IV):**
* Dosing is highly individualized based on serum potassium levels.
* **General guidelines:** 0.25-1 mEq/kg/hour infusion rate.
* **Maximum dose:** Rarely exceeds 40 mEq per dose or 200 mEq per 24 hours, but can be higher in critical situations. **Infusion rate should not exceed 10 mEq/hour peripherally.**
### Dose Adjustments
* Renal impairment: Use with extreme caution. Doses must be reduced. Monitor serum potassium closely.
* Adrenal insufficiency: May require lower doses.
### Contraindications
* Hyperkalemia.
* Conditions causing generalized cellular damage (e.g., extensive burns, crushing injuries) where rapid release of intracellular potassium may lead to fatal hyperkalemia.
* Severe renal impairment.
* Untreated adrenal insufficiency.
* Certain cardiac conduction abnormalities.
### Adverse Effects
* **Common:** Nausea, vomiting, diarrhea, abdominal pain, flatulence.
* **Serious:** Hyperkalemia (especially with rapid IV infusion or in patients with renal impairment), cardiac arrhythmias, cardiac arrest, phlebitis, tissue necrosis (with extravasation of IV solution), gastrointestinal obstruction or perforation (with sustained-release oral forms).
### Key Drug Interactions
* **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia.
* **ACE inhibitors and ARBs:** Increased risk of hyperkalemia.
* **NSAIDs:** May decrease potassium excretion, increasing risk of hyperkalemia.
* **Heparin:** May increase serum potassium by inhibiting aldosterone secretion.
* **Digitalis glycosides:** Hyperkalemia may increase toxicity of digitalis. Hypokalemia may enhance digitalis toxicity.
### Monitoring
* Serum electrolytes (potassium, sodium, chloride) frequently, especially during IV therapy or dose adjustments.
* Renal function (BUN, creatinine).
* Cardiac rhythm (ECG), particularly during IV administration of high doses or in patients with known cardiac disease.
* Signs and symptoms of hypokalemia and hyperkalemia.
### Clinical Pearls
* Oral potassium chloride should be taken with meals or a full glass of water to minimize gastrointestinal irritation.
* Dilute concentrated oral liquid solutions before administration.
* **Never administer potassium chloride as an IV bolus injection.**
* Peripheral IV infusions of potassium chloride should be limited to a concentration of 40 mEq/L and an infusion rate of 10 mEq/hour to reduce the risk of phlebitis and pain. Higher concentrations and rates typically require central venous access and continuous ECG monitoring.
* Patients with hypomagnesemia may also require magnesium replacement as hypokalemia can be refractory to potassium repletion without adequate magnesium.
***
**Disclaimer:** This information is intended for clinical use and is not a substitute for professional medical advice. Always verify current prescribing information with the manufacturer's product insert and consult relevant clinical guidelines and institutional protocols before making any treatment decisions.
